FLWPF (The Flowr) EBIT per Share: $-0.19 (TTM As of Sep. 2022)


What is The Flowr EBIT per Share?

The Flowr FLWPF -90.00% EBIT per Share is $-0.19 as of Sep. 2022.

The Flowr's EBIT per Share for the three months ended in Sep. 2022 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2022 was $-0.19.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for The Flowr's EBIT per Share or its related term are showing as below:

FLWPF's 3-Year EBIT Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.5
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

The Flowr's EBIT for the three months ended in Sep. 2022 was $-1.94 Mil.

The Flowr  (OTCPK:FLWPF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

The Flowr EBIT per Share Related Terms

The Flowr EBIT per Share Historical Data

* Premium members only.

The historical data trend for The Flowr's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Flowr EBIT per Share Chart

The Flowr Annual Data
Trend Jun17 Jun18 Dec19 Dec20 Dec21
EBIT per Share
-0.01 -0.06 -0.28 -0.76 -0.19

The Flowr Quarterly Data
Sep17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.14 -0.01 -0.03 -0.01

The Flowr EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

The Flowr's EBIT per Share for the fiscal year that ended in Dec. 2021 is calculated as

EBIT per Share(A: Dec. 2021 )
=EBIT/Shares Outstanding (Diluted Average)
=-69.547/372.916
=-0.19

The Flowr's EBIT per Share for the quarter that ended in Sep. 2022 is calculated as

EBIT per Share(Q: Sep. 2022 )
=EBIT/Shares Outstanding (Diluted Average)
=-1.938/426.469
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.19 mean?
The Flowr (FLWPF) has a EBIT per Share of $-0.19 as of Sep. 2022. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on The Flowr and its competitors.
Is The Flowr's EBIT per Share too high?
The Flowr's current EBIT per Share is $-0.19.
How does The Flowr's EBIT per Share compare to ZTS and CTLT?
The Flowr's EBIT per Share of $-0.19 can be compared against companies in the Drug Manufacturers industry. The industry median EBIT per Share is 7.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.50, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on The Flowr and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Flowr's current EBIT per Share is $-0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Flowr stock overvalued right now?
The Flowr (FLWPF) has a current EBIT per Share of $-0.19. The current EBIT per Share is $-0.19. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For The Flowr (FLWPF), the current EBIT per Share is $-0.19 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Flowr Business Description

Address 365 Bay Street, Suite 800, Toronto, ON, CAN, M5H 2V1
The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.